O	0	11	Tumorigenic	Tumorigenic	JJ	B-NP
O	12	20	activity	activity	NN	I-NP
O	21	23	of	of	IN	B-PP
O	24	27	rho	rho	JJ	B-NP
O	28	33	genes	gene	NNS	I-NP
O	34	38	from	from	IN	B-PP
O	39	46	Aplysia	Aplysia	NNP	B-NP
O	47	58	californica	californica	NNP	I-NP
O	58	59	.	.	.	O

O	61	64	rho	rho	JJ	B-NP
O	65	70	genes	gene	NNS	I-NP
O	71	75	have	have	VBP	B-VP
O	76	80	been	be	VBN	I-VP
O	81	86	found	find	VBN	I-VP
O	87	89	in	in	IN	B-PP
O	90	94	both	both	CC	B-NP
O	95	100	lower	low	JJR	I-NP
O	101	104	and	and	CC	I-NP
O	105	111	higher	high	JJR	I-NP
O	112	122	eucaryotes	eucaryote	NNS	I-NP
O	122	123	.	.	.	O

O	124	128	They	They	PRP	B-NP
O	129	133	code	code	VBP	B-VP
O	134	137	for	for	IN	B-PP
O	138	146	proteins	protein	NNS	B-NP
O	147	149	of	of	IN	B-PP
O	150	152	21	21	CD	B-NP
O	153	156	kDa	kDa	NN	I-NP
O	156	157	,	,	,	O
O	158	164	highly	highly	RB	B-VP
O	165	174	conserved	conserve	VBN	I-VP
O	175	177	in	in	IN	B-PP
O	178	187	evolution	evolution	NN	B-NP
O	187	188	,	,	,	O
O	189	194	which	which	WDT	B-NP
O	195	201	belong	belong	VBP	B-VP
O	202	204	to	to	TO	B-PP
O	205	208	the	the	DT	B-NP
O	209	220	superfamily	superfamily	NN	I-NP
O	221	223	of	of	IN	B-PP
O	224	227	ras	ras	NN	B-NP
O	228	235	GTPases	GTPas	NNS	I-NP
O	235	236	.	.	.	O

O	237	242	Among	Among	IN	B-PP
O	243	246	the	the	DT	B-NP
O	247	254	members	member	NNS	I-NP
O	255	257	of	of	IN	B-PP
O	258	262	this	this	DT	B-NP
O	263	274	superfamily	superfamily	NN	I-NP
O	275	280	there	there	EX	B-NP
O	281	284	are	be	VBP	B-VP
O	285	293	proteins	protein	NNS	B-NP
O	294	298	with	with	IN	B-PP
O	299	300	a	a	DT	B-NP
O	301	311	regulatory	regulatory	JJ	I-NP
O	312	320	function	function	NN	I-NP
O	320	321	,	,	,	O
O	322	326	such	such	JJ	B-PP
O	327	329	as	as	IN	I-PP
O	330	333	ras	ras	NN	B-NP
O	333	334	,	,	,	O
O	335	338	and	and	CC	O
O	339	347	proteins	protein	NNS	B-NP
O	348	356	involved	involve	VBN	B-VP
O	357	359	in	in	IN	B-PP
B-Multi-tissue_structure	360	369	vesicular	vesicular	JJ	B-NP
O	370	381	trafficking	trafficking	NN	I-NP
O	381	382	,	,	,	O
O	383	387	such	such	JJ	B-PP
O	388	390	as	as	IN	I-PP
O	391	394	the	the	DT	B-NP
O	395	401	family	family	NN	I-NP
O	402	404	of	of	IN	B-PP
O	405	408	rab	rab	NN	B-NP
O	409	417	proteins	protein	NNS	I-NP
O	417	418	.	.	.	O

O	419	421	We	We	PRP	B-NP
O	422	426	have	have	VBP	B-VP
O	427	439	investigated	investigate	VBN	I-VP
O	440	443	the	the	DT	B-NP
O	444	452	putative	putative	JJ	I-NP
O	453	457	role	role	NN	I-NP
O	458	460	of	of	IN	B-PP
O	461	464	rho	rho	JJ	B-NP
O	465	473	proteins	protein	NNS	I-NP
O	474	478	from	from	IN	B-PP
O	479	486	Aplysia	Aplysia	NNP	B-NP
O	487	498	californica	californica	NN	I-NP
O	499	501	as	as	IN	B-PP
O	502	514	transforming	transform	VBG	B-VP
O	515	522	GTPases	GTPas	NNS	B-NP
O	523	532	utilizing	utilize	VBG	B-VP
O	533	536	the	the	DT	B-NP
O	537	541	wild	wild	JJ	I-NP
O	541	542	-	-	HYPH	I-NP
O	542	546	type	type	NN	I-NP
O	547	550	and	and	CC	O
O	551	552	a	a	DT	B-NP
O	553	556	Val	Val	NN	I-NP
O	556	557	-	-	HYPH	B-NP
O	557	559	14	14	CD	I-NP
O	560	566	mutant	mutant	JJ	I-NP
O	566	567	,	,	,	O
O	568	578	equivalent	equivalent	JJ	B-ADJP
O	579	581	to	to	TO	B-PP
O	582	585	the	the	DT	B-NP
O	586	595	oncogenic	oncogenic	JJ	I-NP
O	596	599	Val	Val	NN	I-NP
O	599	600	-	-	HYPH	B-NP
O	600	602	12	12	CD	I-NP
O	603	611	mutation	mutation	NN	I-NP
O	612	614	of	of	IN	B-PP
O	615	618	ras	ras	NN	B-NP
O	619	624	genes	gene	NNS	I-NP
O	625	630	found	find	VBN	B-VP
O	631	633	in	in	IN	B-PP
O	634	640	animal	animal	NN	B-NP
O	641	644	and	and	CC	O
O	645	650	human	human	JJ	B-NP
B-Cancer	651	657	tumors	tumor	NNS	I-NP
O	657	658	.	.	.	O

O	659	663	Over	Over	AFX	B-NP
O	663	664	-	-	HYPH	I-NP
O	664	674	expression	expression	NN	B-NP
O	675	677	of	of	IN	B-PP
O	678	684	either	either	CC	B-NP
O	685	688	rho	rho	JJ	I-NP
O	689	693	gene	gene	NN	I-NP
O	694	697	was	be	VBD	B-VP
O	698	708	sufficient	sufficient	JJ	B-ADJP
O	709	711	to	to	TO	B-VP
O	712	718	confer	confer	VB	I-VP
O	719	728	anchorage	anchorage	NN	B-NP
O	728	729	-	-	HYPH	B-NP
O	730	733	and	and	CC	I-NP
B-Organism_substance	734	739	serum	serum	NN	I-NP
O	739	740	-	-	HYPH	I-NP
O	740	751	independent	independent	JJ	I-NP
O	752	758	growth	growth	NN	I-NP
O	758	759	.	.	.	O

O	760	768	Moreover	Moreover	RB	B-ADVP
O	768	769	,	,	,	O
O	770	774	when	when	WRB	B-ADVP
O	775	785	introduced	introduce	VBN	B-VP
O	786	790	into	into	IN	B-PP
O	791	795	nude	nude	JJ	B-NP
O	796	800	mice	mouse	NNS	I-NP
O	800	801	,	,	,	O
O	802	810	selected	select	VBN	B-NP
O	811	817	clones	clone	NNS	I-NP
O	818	827	generated	generate	VBN	B-VP
O	828	832	from	from	IN	B-PP
O	833	839	either	either	DT	B-NP
O	840	844	gene	gene	NN	I-NP
O	845	849	were	be	VBD	B-VP
O	850	854	able	able	JJ	B-ADJP
O	855	857	to	to	TO	B-VP
O	858	864	induce	induce	VB	I-VP
B-Cancer	865	871	tumors	tumor	NNS	B-NP
O	871	872	,	,	,	O
O	873	881	although	although	IN	B-SBAR
O	882	887	those	those	DT	B-NP
O	888	896	carrying	carry	VBG	B-VP
O	897	900	the	the	DT	B-NP
O	901	908	mutated	mutate	VBN	I-NP
O	909	916	version	version	NN	I-NP
O	917	921	were	be	VBD	B-VP
O	922	926	more	more	RBR	B-ADJP
O	927	936	efficient	efficient	JJ	I-ADJP
O	936	937	.	.	.	O

O	938	950	Pathological	Pathological	JJ	B-NP
O	951	959	analysis	analysis	NN	I-NP
O	960	969	indicated	indicate	VBD	B-VP
O	970	974	that	that	IN	B-SBAR
O	975	984	generated	generate	VBN	B-NP
B-Cancer	985	991	tumors	tumor	NNS	I-NP
O	992	1004	corresponded	correspond	VBD	B-VP
O	1005	1007	to	to	TO	B-PP
O	1008	1012	well	well	RB	B-NP
O	1012	1013	-	-	HYPH	I-NP
O	1013	1027	differentiated	differentiate	VBN	B-VP
B-Cancer	1028	1041	fibrosarcomas	fibrosarcoma	NNS	B-NP
O	1042	1046	with	with	IN	B-PP
O	1047	1055	distinct	distinct	JJ	B-NP
O	1056	1059	and	and	CC	I-NP
O	1060	1072	intersecting	intersecting	JJ	I-NP
B-Cell	1073	1080	bundles	bundle	NNS	I-NP
O	1081	1084	and	and	CC	O
B-Cell	1085	1092	spindle	spindle	NN	B-NP
I-Cell	1093	1098	cells	cell	NNS	I-NP
O	1098	1099	.	.	.	O

O	1100	1102	By	By	IN	B-PP
O	1103	1111	contrast	contrast	NN	B-NP
O	1111	1112	,	,	,	O
O	1113	1116	ras	ras	NN	B-NP
O	1116	1117	-	-	HYPH	B-NP
O	1117	1124	induced	induce	VBN	I-NP
B-Cancer	1125	1131	tumors	tumor	NNS	I-NP
O	1132	1136	were	be	VBD	B-VP
O	1137	1143	poorly	poorly	RB	I-VP
O	1144	1158	differentiated	differentiate	VBN	I-VP
B-Cancer	1159	1172	fibrosarcomas	fibrosarcoma	NNS	B-NP
O	1172	1173	.	.	.	O

O	1174	1178	Thus	Thus	RB	B-ADVP
O	1178	1179	,	,	,	O
O	1180	1183	our	our	PRP$	B-NP
O	1184	1191	results	result	NNS	I-NP
O	1192	1200	indicate	indicate	VBP	B-VP
O	1201	1205	that	that	IN	B-SBAR
O	1206	1211	under	under	IN	B-PP
O	1212	1223	appropriate	appropriate	JJ	B-NP
O	1224	1234	conditions	condition	NNS	I-NP
O	1235	1238	rho	rho	VBP	B-VP
O	1239	1244	genes	gene	NNS	B-NP
O	1245	1253	function	function	VBP	B-VP
O	1254	1256	as	as	IN	B-SBAR
O	1257	1266	oncogenes	oncogene	NNS	B-NP
O	1267	1270	and	and	CC	O
O	1271	1274	may	may	MD	B-VP
O	1275	1279	have	have	VB	I-VP
O	1280	1281	a	a	DT	B-NP
O	1282	1286	role	role	NN	I-NP
O	1287	1289	in	in	IN	B-PP
O	1290	1293	the	the	DT	B-NP
O	1294	1304	regulation	regulation	NN	I-NP
O	1305	1307	of	of	IN	B-PP
O	1308	1321	proliferation	proliferation	NN	B-NP
O	1322	1324	in	in	IN	B-PP
B-Cell	1325	1335	fibroblast	fibroblast	NN	B-NP
I-Cell	1336	1341	cells	cell	NNS	I-NP
O	1341	1342	.	.	.	O

